M&A

Amgen makes progress with its Horizon prize Tepezza, but there's much work left to do
Fierce Pharma
Wed, 02/7/24 - 09:22 pm
Amgen
Horizon Therapeutics
M&A
Tepezza
Gilead will not buy Tizona after paying $300M for the right to do so
Fierce Biotech
Wed, 02/7/24 - 11:17 am
Gilead Sciences
Tizona Therapeutics
M&A
oncology
Amgen earnings boosted by Horizon deal, Gilead quarterly revenue drops
Medical Marketing and Media
Tue, 02/6/24 - 11:41 pm
Amgen
Gilead Sciences
earnings
Horizon Therapeutics
M&A
Novo Holdings acquires Catalent in $16.5B deal, aiming to boost Wegovy production as demand soars
Medical Marketing and Media
Mon, 02/5/24 - 11:06 pm
Novo Nordisk
Catalent
drug manufacturing
Wegovy
M&A
Novartis in the lead to acquire cancer drug developer MorphoSys-sources
NASDAQ.com/Reuters
Mon, 02/5/24 - 11:28 am
Novartis
M&A
MorphoSys
cancer
Novo Nordisk parent to buy Catalent for $16.5 billion to expand Wegovy supply
CNBC
Mon, 02/5/24 - 10:10 am
Novo Nordisk
Catalent
drug manufacturing
M&A
Wegovy
Ozempic
BMS more likely to bet on bolt-ons after recent buying spree
Fierce Biotech
Fri, 02/2/24 - 11:59 am
Bristol Myers Squibb
M&A
earnings
Rite Aid Completes $575 Million PBM Sale To MedImpact
Forbes
Fri, 02/2/24 - 11:41 am
Rite Aid
PBMs
M&A
Elixir
MedImpact
Will Abbott Have a Strong Year for M&A?
Medical Devices and Diagnostics Industry
Thu, 02/1/24 - 11:04 pm
Medtech
Abbott Labs
M&A
earnings
Merck still in the market for deals in the $1B to $15B range, CEO says
Fierce Pharma
Thu, 02/1/24 - 10:56 pm
Merck
M&A
Pharma CEOs
Rob Davis
Prometheus Biosciences
Cook Medical sells ear, nose and throat devices to C2Dx
Medtech Dive
Fri, 01/26/24 - 11:12 am
Medtech
Cook Medical
ENTs
M&A
C2Dx
BMS won out against other pharmas in bid for RayzeBio, just days after competing for Karuna
Fierce Biotech
Thu, 01/25/24 - 09:02 pm
Bristol Myers Squibb
M&A
Rayze Bio
radiopharmaceuticals
Olympus Completes Acquisition of Taewoong Medical
Medical Devices and Diagnostics Industry
Wed, 01/24/24 - 11:34 pm
Medtech
Olympus
M&A
Taewoong Medical
Karuna, Cerevel might be just the start of psychiatry drug M&A
BioPharma Dive
Tue, 01/23/24 - 11:17 am
M&A
Karuna Therapeutics
Cerevel Therapeutics
schizophrenia
AbbVie
Bristol Myers Squibb
Sanofi to buy U.S. drugs project INBRX-101 for about $2.2 billion
Reuters
Tue, 01/23/24 - 10:48 am
Sanofi
M&A
Inhibrx
Another big pharma competed for Karuna, submitting all-cash offer day before BMS deal announcement
Fierce Biotech
Mon, 01/22/24 - 10:17 pm
Karuna Therapeutics
Bristol Myers Squibb
M&A
Sandoz makes its first post-spinout acquisition
Pharmaphorum
Mon, 01/22/24 - 11:12 am
Sandoz
M&A
Coherus
biosimilars
Five years after Shire deal, Takeda looks to reap rewards of latest reinvention
BioPharma Dive
Fri, 01/19/24 - 11:12 am
Takeda
M&A
Shire
fruquintinib
Exkivity
India's Sun Pharma to buy remaining stake in Israeli unit Taro for about $348 mln
Reuters
Thu, 01/18/24 - 05:18 pm
Sun Pharma
Taro
M&A
Illumina's Next Steps for Grail Divestiture
Medical Devices and Diagnostics Industry
Thu, 01/18/24 - 10:54 am
Illumina
Grail
M&A
Medtech

Pages